Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 40, 2129-2134, July 1, 1980]
© 1980 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Minami, A.
Right arrow Articles by Kobayashi, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Minami, A.
Right arrow Articles by Kobayashi, H.

Characterization of Immunosuppressor Cells in Rats Immunized with Solubilized Tumor-associated Antigens Prepared from a Methylcholanthrene-induced Fibrosarcoma1

Akio Minami2, Masaharu Kasai, Yutaka Mizushima, Noritoshi Takeichi, Masuo Hosokawa and Hiroshi Kobayashi

Laboratory of Pathology, Cancer Institute, Hokkaido University School of Medicine, Kita-15-jo, Nishi-7-chome, Kita-ku, Sapporo 060, Japan

Antiimmune responses in rats previously immunized with soluble tumor antigens prepared by sodium deoxycholate (DOC-STA) from chemically induced fibrosarcoma KMT-17 were measured by the Winn assay. Enhancement of tumor growth was demonstrated at a tumor:effector ratio of 1:500 with DOC-STA-immune spleen cells, although inhibition of tumor growth was demonstrated at a tumor:effector ratio of 1:100. The tumor-neutralizing ability of KMT-17-immune spleen cells was abrogated when DOC-STA-immune spleen cells were added to a mixture of KMT-17 cells and KMT-17-immune spleen cells. This suppressor activity of the spleen cells was diminished by the treatment with rabbit anti-rat T-cell serum and immune complement. The suppressor activity of DOC-STA-immune spleen cells was also shown in 51Cr release assay and was specific for the tumor line used. After fractionation of spleen cells from DOC-STA-immune rats by the Ficoll density gradient, the cells in the light layer showed an enhancing effect on tumor growth detected by the Winn assay, whereas the cells in the heavier region of the gradient had an inhibiting effect.

1 This work was supported by a Grant-in-Aid for Cancer Research from the Ministry of Education, Science, and Culture in Japan.

2 To whom requests for reprints should be addressed.

Received 11/20/79. Accepted 4/15/80.




This article has been cited by other articles:


Home page
J Hand Surg Eur VolHome page
A. MINAMI, S. ISHII, T. OGINO, T. OIKAWA, and H. KOBAYASHI
Effect of the Immunological Antigenicity of the Allogeneic Tendons on Tendon Grafting
J Hand Surg Eur Vol., June 1, 1982; Original Series, Volume 14(2): 111 - 119.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1980 by the American Association for Cancer Research.